Investor Relations

Company Overview

NRx Pharmaceuticals is an agile and specialized CNS biopharma company, resolutely focused on meeting very high unmet medical needs for those with severe bipolar despression with suicidality and post-traumatic stress disorder (PTSD).

We are developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior (the "NRx Antidepressant Drug Regimen"). NRx Pharmaceuticals (Nasdaq: NRXP), formerly NeuroRx, is now traded on the Nasdaq Global Select Exchange.

Incorporated Address